Cytokines Alter the Expression and Activity of the Multidrug Resistance Transporters in Human Hepatoma Cell Lines; Analysis Using RT-PCR and cDNA Microarrays

Journal of Pharmaceutical Sciences

Volumn 92, Issue 11, 2003, Pages 2152-2163

  Lee, Gigi ^a   Piquette Miller, Micheline ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cytokine; Hepatoma; MRP transporters; Multidrug resistance; P glycoprotein

Indexed keywords

6 CARBOXYFLUORESCEIN; COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 3; RHODAMINE 123; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASSAY; CANCER CELL; CONTROLLED STUDY; DNA MICROARRAY; GENE ACTIVITY; GENE EXPRESSION; GENE INDUCTION; HEPATOMA CELL; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RODENT;

EID: 0242322421     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10493     Document Type: Article

References (36)

1. Lum BL, Gosland MP. 1995. MDR expression in normal tissues. Hematol Oncol Clin North Am 9:319.
2. Hinoshita E, Uchiumi T, Taguchi K, Kinukawa N, Tsuneyoshi M, Maehara Y, Sugimachi K, Kuwano M. 2000. Increased expression of an ABC superfamily transporter, MRP2, in human colorectal carcinomas. Clin Cancer Res 6:2401-2407.
3. Kool M, Van der Linden M, de Haas M, Schefffer G, de Vree M, et al. 1999. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci USA 96:6914.
4. Kuwano M, Toh S, Uchiumi T, Takano H, Kohno K, Wada M. 1999. Multidrug resistance-associated protein subfamily transporters and drug resistance. Anti-Cancer Drug Design 14:123.
5. Kullak-Ublick G, Beuers U, Paumgartner G. 2000. Hepatobiliary transport. J Hepatol 32:3.
6. Borst P, Evers R, Kool M, Wijnhold J. 1999. The multidrug resistance protein family. Biol Biophys Acta 1461:347.
7. Hirohashi T, Suzuki H, Sugiyama Y. 1999. Characterization of the transport properties of cloned rat MRP3. J Biol Chem 274:15181.
8. KoolM, Van der Linden M, de Haas M, Baas F, Borst P. 1999b. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res 59:175.
9. Madon J, Hagenbuch B, Landmann L, Meier P, Stieger B. 2000. Transport function and hepatocellular localisation of MRP6 in rat liver. Mol Pharmacol 57:634-641.
10. Sukhai M, Piquette-Miller M. 2000a. Regulation of the multidrug resistance genes by stress signals. J Pharm Pharmacol Sci 3:243-253.
11. Piquette-Miller M, Pak A, Kim H, Anari R, Shahzamani A. 1998. Decreased expression and activity of P-glycoprotien in rat liver during acute inflammation. Pharm Res 15:706.
12. Trauner M, Arrese M, Soroka C, Ananthanarayanan M, Koeppel T, Schlosser S, Suchy F, Keppler D, Boyer J. 1997. The rat canalicular conjugate export pump (MRP2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113:255.
13. Suhkai M, Yong A, Pak A, Piquette-Miller M. 2001. Decreased expression of PGP in IL-1β and IL-6 treated rat hepatocytes. Inflamm Res 50:362-370.
14. Hartmann G, Kim H, Piquette-Miller M. 2001. Regulation of the hepatic MDR gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol 1:189-200.
15. Hartmann G, Cheung A, Piquette-Miller M. 2002. Inflammatory cytokines, but not bile acids, regulate cMoat/MRP2 expression in mice. Clin Pharmacol Ther 71:73.
16. Sukhai M, Yong A, Kalistky J, Piquette-Miller M. 2000b. Inflammation and IL-6 mediate reduction in the hepatic expression and transcription of the mdr1a and mdr1b genes. Mol Cell Biol Res Commun 4:248-256.
17. Gutierrez-Ruiz M, Quiroz S, Souza V, Bucio L, Hernandez E, Olivares I, Llorente L, Vorackova F, Kershenobich D. 1999. Cytokines, growth factors and oxidative stress in HepG2 cells treated with ethanol, actaldehyde and LPS. Toxicology 134:197-207.
18. Daffada A, Murray E, Young S. 1994. Control of AP-1 and NF-kappa B activity by IL-1, IL-6 and metals in HepG2 cells. Biochem Biophys Acta 1222:234-240.
19. Malle E, Leonhard B, Knipping G, Sattler W. 1999. Effects of cytokines, butyrate and dexamethasone on serum amyloid A and apolipoprotein A-I synthesis in human HuH-7 hepatoma cells. Scand J Immunol 50:183-187.
20. Stonans I, Stonane E, Rubwurm S, Deigner H, Bohm K, Wiederhold M, Jager L, Reinhart K. 1999. HepG2 human hepatoma cells express multiple cytokine genes. Cytokine 11:151-156.
21. Lee G, Piquette-Miller M. 2001. Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. Can J Physiol Pharmacol 79:876-884.
22. Barriere SL, Lowry SF. 1995. An overview of mortality risk prediction in sepsis. Crit Care Med 2:376.
23. Courtois A, Payen L, Lagadic D, Guillouzo A, Fardel O. 1999. Evidence for a MRP1-related transport system in cultured rat liver biliary epithelial cells. Life Sci 64:763.
24. Van der Kolk D, de Vries E, Koning J, Van den Berg E, Muller M, Vellenga E. 1998. Activity and expression of MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells. Clin Cancer Res 4:1727.
25. Cihlar T, Ho ES. 2000. Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporters. Anal Biochem 283:49-55.
26. Schinkel A, Roelofs M, Borst P. 1991. Characterisation of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonnal antibodies. Cancer Res 51:2628-2635.
27. Raynes J, Beva S. 1993. Inhibition of the acute phase response in human hepatoma cell line. Agents Actions 38:C66-C68.
28. Heller R, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley D, Davis R. 1997. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 94:2150-2155.
29. Taniguchi M, Miura K, Iwao H, Yamanak S. 2001. Quantitative assessment of DNA microarrays-Comparison with Northern blot analyses. Genomics 71:34-39.
30. Richards C, Gauldie J, Baumann H. 1991. Cytokine control of acute phase protein expression. In: Bienvenu J, Fradelizi D, editors. Cytokines and inflammation. Paris: John Libbey Eurotext, p 29-50.
31. Morgan ET. 1997. Regulation of cytochromes P450 during inflammation and infection. Drug Metab Rev 29:1129-1188.
32. Shedlofsky SI, Israel BC, McClain CJ, Hill DB, Blouin RA. 1994. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. J Clin Invest 94:2209-2214.
33. Muntane-Relat J, Ourlin JC, Domergue J, Maurel P. 1995. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 22:1143-1153.
34. Paton TE, Renton KW. 1998. Cytokine-mediated down-regulation of CYP1A1 in Hepa-1 cells. Biochem Pharmacol 55:1791-1796.
35. Strasser SI, Mashford ML, Desmond PV. 1998. Regulation of uridine diphosphate glucuronosyl-transferase during the acute-phase response. J Gastroenterol Hepatol 13:88-94.
36. Schulze A, Downward J. 2000. Analysis of gene expression by microarrays: Cell biologist's gold mine or minefield? J Cell Sci 113:4151-4156.